These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2123602

  • 1. Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction.
    Bleich SD, Nichols TC, Schumacher RR, Cooke DH, Tate DA, Teichman SL.
    Am J Cardiol; 1990 Dec 15; 66(20):1412-7. PubMed ID: 2123602
    [Abstract] [Full Text] [Related]

  • 2. Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).
    Arnout J, Simoons M, de Bono D, Rapold HJ, Collen D, Verstraete M.
    J Am Coll Cardiol; 1992 Sep 15; 20(3):513-9. PubMed ID: 1512327
    [Abstract] [Full Text] [Related]

  • 3. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators.
    N Engl J Med; 1993 Nov 25; 329(22):1615-22. PubMed ID: 8232430
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
    Tebbe U, Windeler J, Boesl I, Hoffmann H, Wojcik J, Ashmawy M, Rüdiger Schwarz E, von Loewis P, Rosemeyer P, Hopkins G.
    J Am Coll Cardiol; 1995 Aug 25; 26(2):365-73. PubMed ID: 7608436
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study.
    Verheugt FW, Liem A, Zijlstra F, Marsh RC, Veen G, Bronzwaer JG.
    J Am Coll Cardiol; 1998 Feb 25; 31(2):289-93. PubMed ID: 9462569
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Patency trials with reteplase (r-PA): what do they tell us?
    Bode C, Nordt TK, Peter K, Smalling RW, Runge MS, Kübler W.
    Am J Cardiol; 1996 Dec 19; 78(12A):16-9. PubMed ID: 8990406
    [Abstract] [Full Text] [Related]

  • 14. A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators.
    Hsia J, Hamilton WP, Kleiman N, Roberts R, Chaitman BR, Ross AM.
    N Engl J Med; 1990 Nov 22; 323(21):1433-7. PubMed ID: 2122251
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG, Laperche T, Golmard JL, Juliard JM, Benamer H, Himbert D, Aubry P.
    J Am Coll Cardiol; 1998 Mar 15; 31(4):776-9. PubMed ID: 9525545
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study Group.
    Haq A, Morgan CD, Wilson RF, Daly PA, Baigrie RS, White CW, Roberts R, Gent M, Armstrong PW.
    Am J Cardiol; 1993 Aug 15; 72(5):379-83. PubMed ID: 8352178
    [Abstract] [Full Text] [Related]

  • 19. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U, Tebbe U, Essen Rv, Haarmann W, Neuhaus KL.
    Am Heart J; 1999 Jan 15; 137(1):34-8. PubMed ID: 9878934
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.